These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations. Salmaninejad A, Ghadami S, Dizaji MZ, Golchehre Z, Estiar MA, Zamani MR, Ebrahimzadeh-Vesal R, Nowroozi MR, Shakoori A. Clin Lab; 2015 Feb; 61(7):749-59. PubMed ID: 26299074 [Abstract] [Full Text] [Related]
27. Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients. Das BR, Bhaumik S, Ahmad F, Mandsaurwala A, Satam H. Pathol Oncol Res; 2015 Jul; 21(3):675-87. PubMed ID: 25637496 [Abstract] [Full Text] [Related]
28. Driver mutations among never smoking female lung cancer tissues in China identify unique EGFR and KRAS mutation pattern associated with household coal burning. Hosgood HD, Pao W, Rothman N, Hu W, Pan YH, Kuchinsky K, Jones KD, Xu J, Vermeulen R, Simko J, Lan Q. Respir Med; 2013 Nov; 107(11):1755-62. PubMed ID: 24055406 [Abstract] [Full Text] [Related]
32. Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer. Deng LL, Deng HB, Lu CL, Guo Y, Wang D, Yan CH, Lv X, Shao YX. J Cancer Res Clin Oncol; 2014 Dec; 140(12):2097-105. PubMed ID: 24994038 [Abstract] [Full Text] [Related]
35. EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. Stella GM, Scabini R, Inghilleri S, Cemmi F, Corso S, Pozzi E, Morbini P, Valentini A, Dore R, Ferrari S, Luisetti M, Zorzetto M. J Cancer Res Clin Oncol; 2013 Aug; 139(8):1327-35. PubMed ID: 23644698 [Abstract] [Full Text] [Related]
36. EGFR/KRAS mutations and gefitinib therapy in Chinese NSCLC patients. Wang Z, Wu YL, Zhang GC, Zhou Q, Xu CR, Guo AL. Onkologie; 2008 Apr; 31(4):174-8. PubMed ID: 18418018 [Abstract] [Full Text] [Related]
37. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients. Ragusa M, Vannucci J, Ludovini V, Bianconi F, Treggiari S, Tofanetti FR, Flacco A, Colella R, Sidoni A, Crinò L, Puma F. Am J Clin Oncol; 2014 Aug; 37(4):343-9. PubMed ID: 23357969 [Abstract] [Full Text] [Related]